Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 99, Issue 8, 2005, Pages 593-598

  Vélez, Iván D ^a   Gilchrist, Katherine ^a   Arbelaez, María P ^a   Rojas, Carlos A ^a   Puerta, Juan A ^a   Antunes, Carlos M F ^b   Zicker, Fabio ^c   Modabber, Farrokh ^c  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c WORLD BANK   (United States)

Author keywords

Colombia; Cutaneous leishmaniasis; Leishmania amazonensis; Leishvacin

Indexed keywords

INACTIVATED VACCINE; LEISHMANIA VACCINE; MEGLUMINE ANTIMONATE; PLACEBO;

ARTICLE; CLINICAL TRIAL; COLOMBIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; ENDEMIC DISEASE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; INCIDENCE; INFECTION CONTROL; INJECTION SITE REACTION; LEISHMANIA; LEISHMANIA PANAMENSIS; LOWER RESPIRATORY TRACT INFECTION; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; RURAL AREA; SKIN LEISHMANIASIS; SKIN TEST; SOLDIER; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME; VOLUNTEER;

ADULT; ANIMALS; COLOMBIA; DOUBLE-BLIND METHOD; HUMANS; INCIDENCE; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; MILITARY PERSONNEL; PROTOZOAN VACCINES; RURAL HEALTH; SURVIVAL ANALYSIS; TREATMENT FAILURE; VACCINES, INACTIVATED;

LEISHMANIA AMAZONENSIS;

EID: 20444451695     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.04.002     Document Type: Article

References (24)

1. M.H. Alimohammadian A. Khamesipour H. Darabi A. Firouz Y. Dowlati F. Modabber The role of BCG in human immune responses induced by multiple injection of autoclaved Leishmania major as a candidate vaccine against leishmaniasis Vaccine 21 2002 174-180
2. C.M.F. Antunes W. Mayrink P.A. Magalhaes Controlled field trial of a vaccine against New World cutaneous leishmaniasis Int. J. Epidemiol. 15 1984 572-580
3. R. Armijos M. Weigel H. Aviles R. Maldonado J. Racines Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: Safety, immunogenicity and efficacy during the first 12 months of follow up J. Infect. Dis. 177 1998 1352-1357
4. J. Convit Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela Clin. Dermatol. 14 1996 479-487
5. A. Corredor R. Kreutzer R. Tesh J. Boshell M. Palau E. Caceres S. Duque D. Pelaez G. Rodriguez S. Nichols C.A. Hernandez A. Morales D. Young C. Ferro de Carrasquilla Distribution and etiology of leishmaniasis in Colombia Am. J. Trop. Med. Hyg. 42 1990 206-214
6. C.R. Davies R. Reithinger D. Campbell-Lendrum D. Feliciangeli R. Borges N. Rodriguez The epidemiology and control of leishmaniasis in Andean Countries Cad. Saude. Publica. 16 2000 925-950
7. P.M. De Luca W. Mayrink J.A. Pinto S.G. Coutinho M.A. Santiago V.P. Toledo C.A. Costa O. Genaro A.B. Reis S. Mendoca A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis Acta Trop. 80 2001 251-260
8. P. Desjeux Leishmaniasis. Public health aspects and control Clin. Dermatol. 14 1996 417-423
9. M.M. Gicheru J.O. Olobo C.O. Anjili A.S. Orago F. Modabber P. Scott Vervet monkey vaccinated with killed Leishmania major parasite and interleukin-12 develop a type 1 immune response but are not protected against challenge infection Infect. Immun. 69 2001 245-251
10. S. Gurunathan C. Prussin D.L. Sacks R.A. Seder Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection Nature Med. 4 1998 1409-1415
11. E. Handman Leishmaniasis: Current status of vaccine development Clin. Microbiol. Rev. 14 2001 229-243
12. J. Karbwang Workbook for Clinical Monitors first ed. 2001 UNDP/World Bank/WHO/TDR, Printing House of Thammasat University
13. D. MacMahon-Pratt J.R. David Monoclonal antibodies that distinguish between New World species of Leishmania Nature 291 1981 581-583
14. W. Mayrink C.A. Da Costa P.A. Magalhaes A field trial of a vaccine against American dermal leishmaniasis Trans. R. Soc. Trop. Med. Hyg. 73 1979 385-387
15. W. Mayrink P. Williams C.A. da Costa P.A. Magalhaes M.N. Melo M. Dias A. Oliveira Lima M.S. Michalick E. Ferreira Carvalho G.C. Barros An experimental vaccine against American dermal leishmaniasis: Experience in the state of Espirito Santo, Brazil Ann. Trop. Med. Parasitol. 79 1985 259-269
16. F. Modabber Vaccines against leishmaniasis Ann. Trop. Med. Parasitol. 89 Suppl. 1 1995 83-88
17. R. Ramirez S. Agudelo C. Muskus J.F. Alzate C. Berberich D. Barker I.D. Vélez Diagnosis of cutaneous leishmaniasis in Colombia: The sample site within lesions influence the sensitivity of parasitologic diagnosis J. Clin. Microbiol. 38 2002 3768-3773
18. N. Saravia K. Weigle C. Navas I. Segura L. Valderrama A.Z. Valencia B. Escorcia D. MacMahon-Pratt Heterogeneity, geographic distribution, and pathogenicity of Leishmania Viannia in Colombia Am. J. Trop. Med. Hyg. 66 2002 738-744
19. I. Sharifi A.R. FeKri M.-R. Aflatonian A. Khamesipour A. Nadim M.-R. Mousavi A.Z. Momeni Y. Dowlati T. Godal F. Zicker P.G. Smith F. Modabber Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam Iran. Lancet 351 1998 1540-1543
20. A. Sjolander T.M. Baldwin J.M. Curtis K.L. Bengtsson E. Handman Vaccination with recombinant parasite surface antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection Vaccine 16 1998 2077-2084
21. Vélez, I.D., Wolff, M., Valderrama, R., Escobar, J.P., Osorio, L., 1991. Communities and environmental risk factors associated with cutaneous leishmaniasis in Montebello, Antioquia Colombia, in: Leishmaniasis Control Strategies: A Critical Evaluation of IDRC/ supported Research. IDRC publications. Ottawa.
22. I.D. Vélez E. Hendrickx O. Roman S. Agudelo Gender and leishmaniosis in Colombia: A redefinition of existing concepts 1996 World Health Organization Geneva WHO/TDR/GTD/RP/97.1
23. I.D. Vélez S. Agudelo P. Arbelaez K. Gilchrist S.M. Robledo J.A. Puerta F. Zicker J. Berman F. Modabber Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: A randomized controlled trial Trans. R. Soc. Trop. Med. Hyg. 94 2000 698-703
24. I.D. Vélez S. Jaramillo S. Agudelo G. Palma J. Gallego B. Travi From 'Milk bread' to control of visceral leishmaniasis among the Zenu Indians of the Caribbean coast of Colombia In: N. Higginbotham R. Briceno-Leon N.E. Johnson (Eds.), Applying Heath Social Science. Best practice in Developing World 2001 Zed Books Ltd London 215-225